Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Diabetes

Stiff shoulders and back? This is my favorite stretch to reverse the damage from sitting at your desk

Try this simple stretch to sooth stiff shoulders from sitting

Fit & Well

FDA approves Wegovy weight-loss pill in first green-lit alternative to injectable GLP-1 drugs

U.S. regulators have approved a pill version of the weight-loss drug Wegovy, a boon for drugmaker Novo Nordisk

The Independent UK

India’s doctors sound alarm over boom in availability of weight loss jabs

Country is facing epidemic of diabetes and obesity, but experts say widespread and unregulated use of weight loss drugs could put patients at risk

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

The ancient diet that can boost heart health

A diet full of fish, berries, and wholegrains may even help reverse liver disease and pre-diabetes

The Independent UK

Weight loss jabs may have hidden bone health benefit, study finds

The Independent UK

The surprising health benefit of drinking tea, according to experts

Experts said daily tea drinkers had a lower risk of osteoporosis

The Independent UK

Wes Streeting ‘not comfortable’ with puberty blocker clinical trial

The Health Secretary made a ban on puberty blockers indefinite in December last year.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Target Bets on Protein, Supplements as Appetite-Suppressing Drugs Gain Popularity

Target expands protein and supplement offerings as appetite-suppressing weight-loss drugs change consumer habits.

International Business Times

Could a drug for narcolepsy change the world?

There are apparently breakthroughs on the way for those with sleep disorders – which sent me down a rabbit hole of research, writes Zoe Williams

The Guardian - UK

Wave Life Sciences One-Shot Obesity Drug Slashes Dangerous Visceral Fat

Wave Life Sciences Ltd. (NASDAQ:WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE GalNAc-siRNA using Wave’s proprietary SpiNA design, for obesity.

Benzinga

New weight-loss drug can burn fat while preserving muscle and appetite, scientists say

Researchers say new compound improves metabolic activity within muscles instead of acting on hunger pathways like Ozempic and Wegovy

The Independent UK

The generation ‘at risk of being left behind’ amid mental health and obesity crisis

They are ‘struggling’ to access support as funding hasn’t kept up with demand

The Independent UK

FDA Warns Against Abbott Glucose Monitor Sensors After Reports Of Over 700 Injuries, 7 Deaths

The U.S. Food and Drug Administration (FDA) in December issued a safety alert urging people with diabetes to stop using select glucose sensors made by Abbott Laboratories’ (NYSE:ABT) Diabetes Care, after the company linked the devices to seven deaths and hundreds of serious injuries.

Benzinga

Diabetic driver in bid to dodge five-death inquest

A diabetic man previously charged over a crash that killed five following an episode will legally challenge being called as a witness in an inquest.

AAP

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns

The U.S. Food and Drug Administration warned people to stop using certain types of glucose monitor sensors that were linked to seven deaths

The Independent UK

Scientists find new link between obesity risk and the quality of your marriage

The love hormone, oxytocin, may be able to influence our relationship with food, researchers say

The Independent UK

7 deaths linked to faulty glucose monitors put in people’s arms, FDA says

About three million devices are affected, though many may be expired or already used

International Business Times UK

WHO Releases Global Guidelines on Using Weight Loss Jabs In Treating Obesity, Warns About Supply Shortage

The World Health Organisation says GLP‑1 weight‑loss jabs, originally for diabetes, can also treat obesity.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Warning over weight loss jab shortage as obesity set to double by 2030

GLP-1 medication, such as Wegovy, was added to the list of ‘essential’ medicines by the World Health Organization in September

The Guardian - UK

Shortage of ‘breakthrough’ weight loss drugs will slow fight against obesity, WHO warns

WHO urges countries to make drugs such as Mounjaro more accessible to people and asks drugs companies to lower prices

Fit & Well

Over 40? A trainer says these are the three exercises you should be doing to promote healthy, active aging

“It’s never too late”—a trainer says these three exercises can help over-40s build the strength and muscle they need to age well

The Guardian - UK

A more nuanced approach to ultra-processed foods is necessary

Letter: The discussion over UPFs distracts from the real public health problem: meat and dairy products, writes Noah Praamsma

The Independent UK

What the shape of your buttocks reveals about your chances of getting diabetes

People with higher fitness had greater gluteus maximus shape when compared to those with a sedentary lifestyle

Tom’s Guide

Not swimming or Pilates! Study finds these two exercises are best when it comes to lowering blood sugar

Here's what this new study means for those with type 2 diabetes.

Benzinga

Novo Nordisk Wants FDA Nod For A Higher-Dose Wegovy

On Wednesday, Novo Nordisk A/S (NYSE:NVO) submitted its supplemental marketing application to the U.S. Food and Drug Administration (FDA) for a higher dose of semaglutide injection 7.2 mg for chronic weight management.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organisation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.